Transient versus Persistent BK Viremia and Long-Term Outcomes after Kidney and Kidney-Pancreas Transplantation

被引:69
|
作者
Elfadawy, Nissreen [1 ]
Flechner, Stuart M. [1 ]
Schold, Jesse D. [2 ]
Srinivas, Titte R. [4 ]
Poggio, Emilio [1 ]
Fatica, Richard [1 ]
Avery, Robin [5 ]
Mossad, Sherif B. [3 ]
机构
[1] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA
[2] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA
[3] Cleveland Clin, Dept Infect Dis, Inst Med, Cleveland, OH 44106 USA
[4] Med Univ S Carolina, Div Nephrol, Charleston, SC 29425 USA
[5] Johns Hopkins Univ, Div Infect Dis, Baltimore, MD USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2014年 / 9卷 / 03期
关键词
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY; RENAL-TRANSPLANTATION; VIRUS NEPHRITIS; VIRAL LOAD; RECIPIENTS; INFECTION; ALLOGRAFT; REPLICATION; PCR;
D O I
10.2215/CJN.08420813
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives The objective was to study the long-term impact of transient versus persistent BK viremia on kidney transplant outcomes. Design, setting, participants, & measurements In total, 609 recipients who underwent kidney transplant from 2007 to 2011 were screened at months 1-12 for the occurrence of polyomavirus BK viremia; 130 patients (21.7%) developed BK viremia during the first year post-transplant. BK viremia patients were classified according to duration of infection (more or less than 3 months), and BK viral loads (more or less than 10,000 copies/ml) were classified as transient low viremia (n=42), transient high viremia (n=18), persistent low viremia (n=23), and persistent high viremia (n=47). All patients were followed a median of 36 (3-66) months. The rates of BK polyomavirus-associated nephropathy, acute rejection, and 1-year graft function were compared with the polyomavirus BK-negative control group. Results Patient and graft survival were not significantly different among the groups. Graft function (creatinine; milligrams per deciliter) at 1 year was significantly worse in the persistent high viremia (1.75 +/- 0.6) and transient high viremia (1.85 +/- 0.7) groups compared with aviremic controls (1.47 +/- 0.4; P=0.01 and P=0.01, respectively). The incidence of BK polyomavirus-associated nephropathy was limited to the persistent high viremia group (1.3%, P<0.001). The transient high viremia (50%) and persistent high viremia (34%) groups showed significantly (P=0.01) increased incidence of acute rejection versus aviremic controls (21.5%), transient low viremia (19%), or persistent low viremia (17.3%) groups. Conclusion Low viral load BK viremia, either transient or persistent, was not associated with long-term transplant outcomes. Persistent high viremia was associated with a greater risk for BK polyomavirus-associated nephropathy and subsequent graft dysfunction. Although transient high viremia was not associated with BK polyomavirus-associated nephropathy, it was associated with worse graft function. These data support the role of surveillance for BK viremia after transplant.
引用
收藏
页码:553 / 561
页数:9
相关论文
共 50 条
  • [31] Ureteral stent duration and the risk of BK polyomavirus viremia or bacteriuria after kidney transplantation
    Wingate, Jonathan T.
    Brandenberger, Jared
    Weiss, Andrew
    Scovel, Lauren G.
    Kuhr, Christian S.
    TRANSPLANT INFECTIOUS DISEASE, 2017, 19 (01)
  • [32] Incidence and Long-Term Prognosis of Cancer After Kidney Transplantation
    Pendon-Ruiz de Mier, V.
    Navarro Cabello, M. D.
    Martinez Vaquera, S.
    Lopez-Andreu, M.
    Aguera Morales, M. L.
    Rodriguez-Benot, A.
    Aljama Garcia, P.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (09) : 2618 - 2621
  • [33] Hyperlipidemia After Kidney Transplantation Long-term Graft Outcome
    Raees-Jalali, Ghanbarali
    Eshraghian, Ahad
    Faghihi, Alireza
    Roozbeh, Jamshid
    Sagheb, Mohammad Mehdi
    Eshraghian, Hamed
    Behzadi, Saeed
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2012, 6 (01) : 49 - 55
  • [34] The value of long-term protocol biopsies after kidney transplantation
    Tanabe, Tatsu
    NEPHROLOGY, 2014, 19 : 2 - 5
  • [35] The Impact of Hypomagnesemia on the Long-Term Evolution After Kidney Transplantation
    Ratiu, Ioana Adela
    Moisa, Corina
    Marc, Luciana
    Olariu, Nicu
    Ratiu, Cristian Adrian
    Bako, Gabriel Cristian
    Ratiu, Anamaria
    Fratila, Simona
    Teusdea, Alin Cristian
    Ganea, Mariana
    Indries, Mirela
    Filip, Lorena
    NUTRIENTS, 2025, 17 (01)
  • [36] Outcomes of Simultaneous Kidney-Pancreas Transplantation With Positive Cross-Match
    Heilman, R. L.
    Chakkera, H.
    Mazur, M.
    Petrides, S.
    Moss, A.
    Mekeel, K.
    Mulligan, D.
    Reddy, K. S.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (01) : 303 - 306
  • [37] Belatacept and Long-Term Outcomes in Kidney Transplantation REPLY
    Vincenti, Flavio
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (26): : 2600 - 2601
  • [38] Effects of bisphosphonates on long-term kidney transplantation outcomes
    Song, Seung Hwan
    Choi, Hoon Young
    Kim, Ha Yan
    Nam, Chung Mo
    Jeong, Hyeon Joo
    Kim, Myoung Soo
    Kim, Soon I. I.
    Kim, Yu Seun
    Ha Huh, Kyu
    Kim, Beom Seok
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (04) : 722 - 729
  • [39] Perioperative and long-term outcomes in octogenarians after kidney transplantation: the US perspective
    Ravinuthala, Abhishek
    Mei, Xiaonan
    Daily, Michael
    Shah, Malay
    Castellanos, Analia
    Berger, Jonathan
    Gedaly, Roberto
    CLINICAL NEPHROLOGY, 2017, 87 (02) : 69 - 75
  • [40] Myocardial ischemia by radionuclide imaging and long-term outcomes after kidney transplantation
    Low, Sanmay
    Chua, Horng-Ruey
    Wong, Raymond
    Goh, Angeline
    Ng, Yue-Harn
    Teo, Boon-Wee
    Vathsala, Anantharaman
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (10) : 1995 - 2003